Dr. Garren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-498-5710
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1994 - 1997
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1993 - 1994
- David Geffen School of Medicine at UCLAClass of 1993
Certifications & Licensure
- CA State Medical License 1994 - 2026
Publications & Presentations
PubMed
- 139 citationsPhase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis.Hideki Garren, William H. Robinson, Eva Krasulova, Eva Havrdova, Congor Nadj
Annals of Neurology. 2008-05-01 - 125 citationsPlasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+ T Cells in Type 1 DiabetesBart O. Roep, Nanette Solvason, Peter A. Gottlieb, Joana R. F. Abreu, Leonard C. Harrison
Science Translational Medicine. 2013-06-26 - 32 citationsTransient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD MiceGhanashyam Sarikonda, Sowbarnika Sachithanantham, Yulia Manenkova, Tinalyn Kupfer, Amanda L. Posgai
Plos One. 2013-02-06
Press Mentions
- Biotech Company Prothena Taps Walgreens to Recruit Patients for Alzheimer's Drug ResearchApril 13th, 2023
- Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer’s Disease Clinical TrialApril 13th, 2023
- Prothena Corporation Plc (NASDAQ:PRTA) Q4 2022 Earnings Call TranscriptFebruary 28th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: